Showing 1711 results
-
Press release /Sandoz is the first company to receive approval of a biosimilar in the US through the new FDA biosimilars pathway established under BPCIA Zarxio is approved for all indications included in the…
-
Ad hoc release /Ad hoc announcement pursuant to Art. 53 LR Transformation into a “pure-play” innovative medicines business is complete, with the spin-off of Sandoz; commentary below is on continuing…
-
Story /NIBR investigator develops technology that uses tumor DNA in the blood for diagnostics
-
Press release /Basel, September 4, 2017 - Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, has informed the Board of Directors of his desire to step down as CEO in 2018, after eight years in position. The…
-
Featured News / -
Media Library / -
Story /Christine Hà lost her vision at a young age – and went on to become an award-winning chef.
-
Story /Novartis opens up a path of research to protect proteins that guard against cancer.
-
Story /Jordan, a melanoma survivor, shares her experience with melanoma, BRAF mutation testing and the importance of patient empowerment.
-
Media Library /